FREE Case Review (866) 588-0600

Illinois Mounjaro Stomach Paralysis Lawsuit (2024 Update)

Awards & recognition
Collen Clark Published by Collen Clark
Free Confidential Mounjaro Stomach Paralysis Lawsuit Review
If you or a loved one suffered from stomach paralysis or another injury after taking Mounjaro or another weight loss medication, you should contact our lawyers today.

You may be entitled to compensation by filing a Mounjaro Stomach Paralysis Lawsuit and our lawyers can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm today by dialing (866) 588-0600.

Start My Free Case Review

Quick Summary

  • If you’ve experienced stomach paralysis symptoms after using Mounjaro, you may be aware of the emerging Illinois Mounjaro stomach paralysis lawsuit. The increasing number of adverse event reports related to Mounjaro has led to significant legal actions in Illinois.
  • This article dives into the core of these legal claims against Eli Lilly, outlining what patients need to know about their rights and potential avenues for compensation in Illinois. Stay informed on the latest legal actions, key considerations for filing a claim, and aspects of the ongoing litigation.
  • If you or someone you know has experienced complications from Mounjaro, Schmidt & Clark, LLP, is here to help. Renowned for our expertise in plaintiff representation, our primary goal is to ensure you receive the justice and compensation you deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by navigating the complexities of a legal claim, which can be overwhelming, especially when dealing with the serious health implications of stomach paralysis.

S&C offers a comprehensive approach to managing your claim, which includes the following key steps:

  • Free initial consultation to assess your case
  • Collaboration with medical experts to gather the necessary evidence
  • Compassionate guidance throughout the legal process

Mounjaro Stomach Paralysis Lawsuit

The legal landscape is rapidly evolving as more individuals come forward, sharing stories of severe gastrointestinal issues following Mounjaro’s use. Studies have also indicated a potential increased risk of bowel obstruction among Mounjaro users.

Initially approved for diabetes treatment, Mounjaro is now at the center of a potential legal storm due to these debilitating conditions. Reports of severe stomach problems from Mounjaro users in Illinois have been significant, indicating a troubling link between the medication and severe gastrointestinal issues.

Although the manufacturer company, Eli Lilly, has acknowledged that delayed gastric emptying is a known side effect, the manufacturer of Mounjaro has yet to address the severe stomach problems and severe gastrointestinal events linked to this medication.

Patients affected by this are speaking out. Each new Mounjaro stomach paralysis lawsuit draws more attention, encouraging others to share their experiences of stomach pain and paralyzed stomach muscles.

What Is Mounjaro?

According to Healthline, Mounjaro is a medication known by its generic name, tirzepatide, and is primarily prescribed for the treatment of type 2 diabetes. Developed by Eli Lilly, Mounjaro works by mimicking the effects of two hormones, GLP-1 and GIP, which help regulate blood sugar levels. This dual-action mechanism makes it a unique and powerful option for managing diabetes [1].

The drug has gained attention not only for its efficacy in controlling blood sugar but also for its potential benefits in weight loss, which has led to its off-label use for obesity management.

However, these benefits come with significant risks, as evidenced by the growing number of reports linking Mounjaro to severe gastrointestinal issues, including stomach paralysis. Mounjaro can delay stomach emptying, leading to conditions like gastroparesis.

The scrutiny intensifies on diabetes drugs like Mounjaro and Ozempic when they are used for purposes other than blood sugar regulation, such as weight loss. With the trend of prescribing Ozempic for weight loss on the rise, questions about the safety and long-term effects of these medications are increasingly coming to the forefront.

These medications can affect the digestive system, slowing the movement of food from the stomach to the intestines. The lure of rapid weight loss is powerful, but it is imperative to consider the potential gastrointestinal risks that accompany such medications.

As clinical trials continue to evaluate the efficacy and safety of these weight-loss drugs, the medical community and patients alike must remain vigilant. The allure of shedding pounds quickly must be weighed against the potential for serious complications, and the role of pharmaceutical companies in accurately representing their weight loss medications is more crucial than ever.

Was Mounjaro Recalled?

Mounjaro was not recalled. Despite the rising concerns and legal actions surrounding its severe gastrointestinal side effects, the FDA has not issued a recall for Mounjaro. Pharmaceutical companies like Eli Lilly are required to provide comprehensive information regarding the risks associated with their medications, ensuring patient safety remains a priority.

According to the FDA, the agency continues to monitor adverse event reports to ensure Mounjaro’s ongoing safety. The FDA’s ongoing evaluation of reports regarding suicidal thoughts or actions in patients taking certain medications, including Mounjaro, underscores the importance of monitoring and transparent reporting [2].

The FDA Adverse Event Reporting System (FAERS) is a vital tool for healthcare professionals and patients to report adverse reactions, helping to ensure the ongoing safety of medications post-approval.

Pharmaceutical companies must ensure that information about potential adverse events is accessible and transparent, enabling informed decision-making by all parties involved. This responsibility includes providing adequate warning labels and promptly updating them as new safety information emerges.

Side Effects of Mounjaro

According to 2023 research by NIH, reports of gastrointestinal issues have surfaced, with up to 50% of patients experiencing notable discomfort following a 15-mg dose of tirzepatide [3].

Mounjaro has been linked to delayed gastric emptying, which can lead to severe gastrointestinal issues.

Some of the symptoms include:

  • Gastroparesis, or stomach paralysis, which involves weakened stomach muscles that fail to propel food into the intestines
  • Distressing symptoms such as nausea, vomiting, bloating, and abdominal pain
  • The potential for more severe health issues, including acute organ failure and even pancreatitis

These symptoms can be concerning and should be monitored closely. If you experience any of these symptoms, it is important to consult with your healthcare provider.

Patients have reported various gastrointestinal disorders, including gastroparesis and bowel obstruction. Symptom severity can fluctuate, with an increased risk of digestive complications correlating to higher doses of Mounjaro.

Serious side effects of Mounjaro that have been reported include pancreatitis (swelling of the pancreas), gallbladder problems, and hypoglycemia (low blood sugar) – Amber Watson, PharmD, BCMAS, Assistant Medical Director at NashBio

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

To qualify for a Mounjaro stomach paralysis lawsuit you must have a documented diagnosis of stomach paralysis or gastroparesis that can be linked to the use of Mounjaro.

You must prove usage and that your complications are directly related to Mounjaro. Evidence of usage includes prescription records, pharmacy receipts, and even empty medication bottles.

The Status Of The Mounjaro Lawsuit Litigation in Illinois

The Illinois legal landscape is shifting as the Mounjaro stomach paralysis lawsuits converge into a consolidated front. This consolidation is a strategic move that aims to harmonize judicial rulings and expedite the legal process, offering a glimmer of hope for quicker resolutions for those affected.

With such a significant number of lawsuits now centralized, attention is turning to upcoming decisions that could set precedents for future Mounjaro class action lawsuits.

Many people’s eyes are fixed on Illinois, as the state plays a pivotal role in shaping the outcomes for Mounjaro users across the nation. With recent developments, the litigation scene for Mounjaro and similar GLP-1 drugs is transforming, indicating a new phase in this legal saga.

As of February 2024, lawsuits related to injuries caused by these drugs have been consolidated into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, a move that aims to centralize and streamline the process for all parties involved.

The consolidation into an MDL was driven by the need to expedite evidence gathering and facilitate a more efficient pre-trial process, which could lead to quicker resolutions for victims.

Mounjaro Lawsuit Settlement Amounts in Illinois

The quest for compensation after a Mounjaro-induced injury is multifaceted. Plaintiffs may seek compensation for a range of damages, including medical bills, lost income, and emotional suffering, which is more nebulous but no less significant.

Settlement amounts can vary widely depending on the specifics of each case, but estimates suggest that plaintiffs may receive anywhere from $50,000 to $500,000 or more.

The outcome of a lawsuit-whether resolved through a settlement or a court verdict-will determine the extent of the compensation for the plaintiff’s injuries.

Compensation can be possible at various stages of the litigation process. For some, a pre-trial settlement offers a quicker resolution, while others may find their case going to trial with the potential for a jury verdict that reflects the true extent of their losses. Whatever the path, the goal remains the same: to secure a measure of justice for the harm endured.

Filing a Mounjaro Stomach Paralysis Lawsuit in Illinois

The journey to justice starts with selecting an attorney experienced in product liability against pharmaceutical firms. With proper legal representation, gathering medical documentation to substantiate your stomach paralysis claim becomes manageable.

Types of Evidence To Present

When preparing for a Mounjaro stomach paralysis lawsuit, presenting comprehensive and compelling evidence is crucial to substantiate your claim.

Below are the key types of evidence that can significantly bolster your case:

  1. Medical Records: Detailed medical documentation that shows your diagnosis of stomach paralysis or gastroparesis. This includes doctor’s notes, diagnostic tests (such as gastric emptying studies), and any treatment plans or interventions you have undergone.
  2. Prescription Records: Proof of Mounjaro usage through pharmacy receipts, prescription records, and even empty medication bottles. These records must clearly link your use of Mounjaro to your diagnosis.
  3. Personal Testimony: A detailed account of your symptoms and how they have impacted your daily life. This can include a personal journal documenting your day-to-day struggles, physical limitations, and the emotional toll of living with stomach paralysis.
  4. Expert Testimony: Collaboration with medical experts who can provide professional opinions on the link between Mounjaro and your condition. These experts can offer insights into the medical plausibility of your claim and testify on your behalf.
  5. Correspondence with Healthcare Providers: Emails, letters, or other communications with your healthcare providers discussing your symptoms, treatment options, and the suspected link to Mounjaro.

By gathering and presenting these types of evidence, you can build a robust case that clearly demonstrates the impact of Mounjaro on your health and strengthens your position in seeking compensation.

What is the Statute of Limitations for the Mounjaro Lawsuit in Illinois?

The statute of limitations for the Mounjaro lawsuit in Illinois is two years from the date you discovered or reasonably should have discovered the injury. This critical legal concept determines the time frame within which you must file a lawsuit.

In product liability cases, including those involving pharmaceutical drugs like Mounjaro, acting promptly is essential.

Related Articles:

See all related dangerous drug lawsuits our attorneys covered so far.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get Your Free Consultation From Our Illinois Lawyers

The Schmidt & Clark, LLP law firm stands ready to assist you during these difficult times. If you or a loved one has experienced gastrointestinal issues from weight loss drugs like Mounjaro, reach out to us without delay.

Our experienced team is well-versed in managing such cases and will navigate you through the legal process. We will clarify your rights and determine your eligibility for a lawsuit concerning these complications.

Benefit from a free case evaluation, and remember, we only collect fees if we win your case. Trust that our dedication to your case is unwavering, and we will treat it with the same care as if you were part of our family. Contact us today for a thorough review of your concerns.



Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.